Results 211 to 220 of about 11,206 (235)
Some of the next articles are maybe not open access.
Growth Hormone & IGF Research, 2000
Synthetic GH-releasing peptides such as GHRP-6 are potent GH secretagogues (GHSs) in several species, but attempts to stimulate growth by continuous GHS exposure have had limited success. GHSs also release ACTH and adrenal steroids. Since glucocorticoid excess is associated with poor linear growth, stimulation of the hypothalamo-pituitary-adrenal (HPA)
G B, Thomas +3 more
openaire +2 more sources
Synthetic GH-releasing peptides such as GHRP-6 are potent GH secretagogues (GHSs) in several species, but attempts to stimulate growth by continuous GHS exposure have had limited success. GHSs also release ACTH and adrenal steroids. Since glucocorticoid excess is associated with poor linear growth, stimulation of the hypothalamo-pituitary-adrenal (HPA)
G B, Thomas +3 more
openaire +2 more sources
[Molecular analysis of the human "growth hormone secretagogue"-receptor].
Medizinische Klinik (Munich, Germany : 1983), 1999Growth hormone secretagogues (GHS) are highly potent synthetic peptides which release growth hormone (GH) by activation of a growth hormone-releasing hormone-independent signal cascade. A specific growth hormone secretagogue receptor (GHS-R) has been isolated, its endogenous ligand is still unknown.
S, Petersenn +3 more
openaire +1 more source
Growth hormone secretagogue receptor expression in human pituitary tumors.
The Journal of clinical endocrinology and metabolism, 1999The GH secretagogue (GHS) receptor (GHS-R) has been characterized and cloned. It is a member of a family of seven transmembrane receptors and is closely related to the neurotensin and TRH receptors. To determine the expression of this receptor in normal anterior pituitary and in 24 human pituitary adenomas, we analyzed GHS-R messenger ribonucleic acid (
M M, Skinner +4 more
openaire +1 more source
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Cancer treatment and survivorship statistics, 2022
Ca-A Cancer Journal for Clinicians, 2022Kimberly D Miller +2 more
exaly
GHSR: Growth Hormone Secretagogue Receptor
2016Yue Yin, Shiying Liu, Weizhen Zhang
openaire +1 more source
Breast cancer statistics, 2019
Ca-A Cancer Journal for Clinicians, 2019Carol E Desantis, Jiemin, Mia M Gaudet
exaly
Structure and regulation of the growth hormone secretagogue receptor.
Minerva endocrinologica, 2003Synthetic growth hormone secretagogues (GHS) stimulate growth hormone release through binding to a recently cloned specific growth hormone secretagogue receptor (GHS-R). Ghrelin, the endogenous ligand of this receptor, is part of a new endocrine pathway controlling GH secretion.
openaire +1 more source
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly

